Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

The oral PI3Kdelta inhibitor Linperlisib and Obinutuzumab as response-dependent, first-line regimen for marginal zone lymphoma: A prospective single-arm Phase Ib/II Study

Jia Li, Xingtong Wang, Wei Guo, Yangzhi Zhao, chunshui liu, Ou Bai

Blood (2025) 146 (Supplement 1): 7099.

https://doi.org/10.1182/blood-2025-7099

Published: 2025

Journal Articles

Frontline brentuximab vedotin and PD-1 inhibitors in elderly Chinese Hodgkin lymphoma: Real-world survival benefits validated by geriatric and biomarker correlates

Blood (2025) 146 (Supplement 1): 1843.

https://doi.org/10.1182/blood-2025-1843

Published: 2025

Journal Articles

Efficacy and safety of R-CDOP in treatment-Naïve non-Hodgkin lymphoma with high tumor burden: A multicenter, prospective study

Wei Guo, Yangzhi Zhao, Jia Li, Xingtong Wang, chunshui liu, Junna Li, Ou Bai

Blood (2025) 146 (Supplement 1): 1921.

https://doi.org/10.1182/blood-2025-1921

Published: 2025

Journal Articles

Clinical study on the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor injection (PEG-rhG-CSF) in autologous hematopoietic stem cell mobilization for lymphoma - Results of interim analysis

Wei Guo, Yangzhi Zhao, Jia Li, Xingtong Wang, Junna Li, chunshui liu, Ou Bai

Blood (2025) 146 (Supplement 1): 2408.

https://doi.org/10.1182/blood-2025-2408

Published: 2025

Journal Articles

Characteristics, treatment outcomes, and prognostic analysis of 118 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia

Yangzhi Zhao, wei Guo, Jia Li, Xingtong Wang, junna Li, chunshui liu, Ou Bai

Blood (2025) 146 (Supplement 1): 3608.

https://doi.org/10.1182/blood-2025-3608

Published: 2025

Journal Articles

Comparative efficacy and safety of obinutuzumab- versus rituximab-based immunochemotherapy in newly diagnosed burkitt lymphoma: A single-center retrospective study

Ying Zhang, Wei Guo, Haotian Wang, Luming Cao, Jihong Xu, Xin Wan, Jia Li, Zhumei Zhan, Rui Xing, Ou Bai

Blood (2025) 146 (Supplement 1): 6886.

https://doi.org/10.1182/blood-2025-6886

Published: 2025

Journal Articles

Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)

Xin Li, Jia Wei, Dong-feng Zeng, Shu-nan Qi, Bingzong Li, Wei Guo, Li Wang, Yajun Li, Xudong Zhang, Yong Yang, Shukai Qiao, Yan Zeng, Yunfei Song, Jing-wen Wang, Jian-min Ma, Liang Wang

Blood (2024) 144 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2024-206489

Published: 2024

Journal Articles

The Short-Term Efficacy and Safety of Brentuximab Vedotin Chemotherapy Combined with Chidamide in the Treatment of CD30-Positive Peripheral T-Cell Lymphoma

Xingtong Wang, Wei Guo, Yangzhi Zhao, Jia Li, Ou Bai

Blood (2024) 144 (Supplement 1): 4447.

https://doi.org/10.1182/blood-2024-206302

Published: 2024

Journal Articles

Exploration of Rituximab Plus Lenalidomide（R 2 ）in Newly Diagnosed Diffuse Large B Cell Lymphoma with Adverse Prognostic Factors As Maintenance Therapy

Jia Li, Ou Bai, Yangzhi Zhao, Wei Guo, Xingtong Wang

Blood (2024) 144 (Supplement 1): 1723.

https://doi.org/10.1182/blood-2024-204951

Published: 2024

Journal Articles

Chidamide: A New Exploration of Maintenance Therapy for DLBCL Patients with HBV Infection

Ying Zhang, Wei Guo, Yangzhi Zhao, Zhumei Zhan, Haotian Wang, Zhe Li, Bowen Wang, Luming Cao, Xin Wan, Jia Li, Ou Bai

Blood (2024) 144 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2024-204677

Published: 2024

Journal Articles

A Retrospective Analysis on the Efficacy and Saftey of Obinutuzumab in the Treatment of Non-Hodgkin B Cell Lymphoma

Yangzhi Zhao, Wei Guo, Jia Li, Xingtong Wang, Xin Wan, Junna Li, Ou Bai

Blood (2023) 142 (Supplement 1): 4427.

https://doi.org/10.1182/blood-2023-187801

Published: 2023

Journal Articles

A Multicenter, Prospective Clinical Study of the R-CDOP Regimen in Previously Untreated Non-Hodgkin Lymphoma with High Tumor Burden

Wei Guo, Xingtong Wang, Yangzhi Zhao, Jia Li, Chunshui Liu, Xin Wan, Ou Bai

Blood (2023) 142 (Supplement 1): 1736.

https://doi.org/10.1182/blood-2023-188580

Published: 2023

Journal Articles

Lenalidomide in Combination with Etoposide Induced Ferroptotic Cell Death in DLBCL

Jia Li, Wei Guo, Yangzhi Zhao, Xingtong Wang, Xin Wan, Ou Bai

Blood (2023) 142 (Supplement 1): 5788.

https://doi.org/10.1182/blood-2023-186912

Published: 2023

Journal Articles

The Combination of Pegfilgrastim and Filgrastim Improves the Outcomes of Mobilization and Engraftment after Transplantation of Autologous Hematopoietic Stem Cells for the Treatment of Lymphoma

Xingtong Wang, Wei Guo, Yangzhi Zhao, Jia Li, Xin Wan, Ou Bai

Blood (2023) 142 (Supplement 1): 4891.

https://doi.org/10.1182/blood-2023-182840

Published: 2023

Journal Articles

The Clinical and Translational Exploration of the Role of S1P/SPHK1 Pathway in Non-Hodgkin Lymphoma with Obesity

Xingtong Wang, Wei Guo, Xiaoju Shi, Jia Li, Min Tan, Yan Li, Ou Bai

Blood (2022) 140 (Supplement 1): 9249–9250.

https://doi.org/10.1182/blood-2022-169371

Published: 2022

Journal Articles

The Short-Term Efficacy and Safety of Obinutuzumab Plus Chemotherapy in B-NHL with High Tumor Burden: A Real-World, Retrospective Study

Xin Wan, Wei Guo, Xingtong Wang, Yangzhi Zhao, Jia Li, Junna Li, Zhumei Zhan, Ou Bai

Blood (2022) 140 (Supplement 1): 11977–11978.

https://doi.org/10.1182/blood-2022-169343

Published: 2022

Journal Articles

Clinical Features and Prognosis of Double Primary Malignant Neoplasms in Patients with Non-Hodgkin Lymphoma

Zhumei Zhan, Wei Guo, Xingtong Wang, Jia Li, Xin Wan, Ou Bai

Blood (2022) 140 (Supplement 1): 11968–11969.

https://doi.org/10.1182/blood-2022-169463

Published: 2022

Journal Articles

FFA Promoting Proliferation and Migration Via Classical Wnt Signaling Pathway in Peripheral T Cell Lymphoma

Wei Guo, Xingtong Wang, Chunshui Liu, Yan Li, Ou Bai

Blood (2022) 140 (Supplement 1): 11506–11507.

https://doi.org/10.1182/blood-2022-170462

Published: 2022

Journal Articles

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Wei Guo, Xiaomeng Feng, Yinping Wang, Jia Li, Yangzhi Zhao, Limei Qu, Xu Yan, Junna Li, Qiang Guo, Ken H. Young, Ou Bai

Blood (2021) 138 (Supplement 1): 4563.

https://doi.org/10.1182/blood-2021-147695

Published: 2021

Journal Articles

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Wei Guo, Yangzhi Zhao, Xingtong Wang, Jia Li, Qiang Guo, Junna Li, Ken H. Young, Ou Bai

Blood (2021) 138 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2021-152164

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The oral PI3Kdelta inhibitor Linperlisib and Obinutuzumab as response-dependent, first-line regimen for marginal zone lymphoma: A prospective single-arm Phase Ib/II Study

Frontline brentuximab vedotin and PD-1 inhibitors in elderly Chinese Hodgkin lymphoma: Real-world survival benefits validated by geriatric and biomarker correlates

Efficacy and safety of R-CDOP in treatment-Naïve non-Hodgkin lymphoma with high tumor burden: A multicenter, prospective study

Clinical study on the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor injection (PEG-rhG-CSF) in autologous hematopoietic stem cell mobilization for lymphoma - Results of interim analysis

Characteristics, treatment outcomes, and prognostic analysis of 118 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia

Comparative efficacy and safety of obinutuzumab- versus rituximab-based immunochemotherapy in newly diagnosed burkitt lymphoma: A single-center retrospective study

Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)

The Short-Term Efficacy and Safety of Brentuximab Vedotin Chemotherapy Combined with Chidamide in the Treatment of CD30-Positive Peripheral T-Cell Lymphoma

Exploration of Rituximab Plus Lenalidomide（R 2 ）in Newly Diagnosed Diffuse Large B Cell Lymphoma with Adverse Prognostic Factors As Maintenance Therapy

Chidamide: A New Exploration of Maintenance Therapy for DLBCL Patients with HBV Infection

A Retrospective Analysis on the Efficacy and Saftey of Obinutuzumab in the Treatment of Non-Hodgkin B Cell Lymphoma

A Multicenter, Prospective Clinical Study of the R-CDOP Regimen in Previously Untreated Non-Hodgkin Lymphoma with High Tumor Burden

Lenalidomide in Combination with Etoposide Induced Ferroptotic Cell Death in DLBCL

The Combination of Pegfilgrastim and Filgrastim Improves the Outcomes of Mobilization and Engraftment after Transplantation of Autologous Hematopoietic Stem Cells for the Treatment of Lymphoma

The Clinical and Translational Exploration of the Role of S1P/SPHK1 Pathway in Non-Hodgkin Lymphoma with Obesity

The Short-Term Efficacy and Safety of Obinutuzumab Plus Chemotherapy in B-NHL with High Tumor Burden: A Real-World, Retrospective Study

Clinical Features and Prognosis of Double Primary Malignant Neoplasms in Patients with Non-Hodgkin Lymphoma

FFA Promoting Proliferation and Migration Via Classical Wnt Signaling Pathway in Peripheral T Cell Lymphoma

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only